Valneva SE (Austria) Investor Sentiment

VLA Stock  EUR 1.84  0.04  2.13%   
Under 61% of Valneva SE's investor base is looking to short. The analysis of current outlook of investing in Valneva SE suggests that many traders are alarmed regarding Valneva SE's prospects. Valneva SE's investing sentiment shows overall attitude of investors towards Valneva SE.
  
over a year ago at news.google.com         
France stocks higher at close of trade CAC 40 up 0.12 percent By ... - Investing.com
Google News at Macroaxis
over a year ago at news.google.com         
One step closer to a single-shot chikungunya vaccine update on Valnevas live-attenuated vaccine cand...
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Announces Filing of 2022 Universal Registration Document and US Form 20-F - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Valneva to Present on its Chikungunya Vaccine Candidate and Host a Roundtable at the 23rd World Vacc...
Google News at Macroaxis
over a year ago at news.google.com         
Valneva A Biotech Company with Promising Investment ... - Best Stocks
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Full Year 2022 Earnings Revenues Beat Expectations, EPS Lags - Simply Wall St
Google News at Macroaxis
over a year ago at news.google.com         
Valneva SE earnings missed by 0.59, revenue fell short of ... - Investing.com
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Shares Fall on Widened 2022 Net Loss, Lower Revenue Outlook - MarketWatch
Google News at Macroaxis
over a year ago at news.google.com         
Valneva SEs Stock Has Shown Weakness Lately But Financial Prospects Look Decent Is The Market Wrong ...
Google News at Macroaxis
over a year ago at news.google.com         
VBI VACCINES INCBC MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATI...
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Shares Updated Data From Now Shelved COVID-19 Vaccine Development Program - Yahoo Finance
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Provides Clinical and Regulatory Updates for its COVID-19 ... - Marketscreener.com
Google News at Macroaxis
over a year ago at news.google.com         
Valneva Trading Down 6.2 percent - ETF Daily News
Google News at Macroaxis
over a year ago at news.google.com         
Valneva shareholders YoY returns are lagging the companys 30 percent three-year earnings growth - Si...
Google News at Macroaxis
over a year ago at news.google.com         
Pharma Giant Pfizer Looks Strong for Investors, Despite COVID ... - Nasdaq
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Valneva SE that are available to investors today. That information is available publicly through Valneva media outlets and privately through word of mouth or via Valneva internal channels. However, regardless of the origin, that massive amount of Valneva data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Valneva SE news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Valneva SE relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Valneva SE's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Valneva SE alpha.

Valneva SE Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Valneva Stock analysis

When running Valneva SE's price analysis, check to measure Valneva SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Valneva SE is operating at the current time. Most of Valneva SE's value examination focuses on studying past and present price action to predict the probability of Valneva SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Valneva SE's price. Additionally, you may evaluate how the addition of Valneva SE to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format